A detailed history of Quantbot Technologies LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Quantbot Technologies LP holds 169 shares of UTHR stock, worth $53,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169
Holding current value
$53,581
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$210.76 - $249.51 $35,618 - $42,167
169 New
169 $38,000
Q2 2023

Aug 08, 2023

BUY
$205.19 - $232.99 $53,964 - $61,276
263 Added 78.51%
598 $132,000
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $27,901 - $36,178
-131 Reduced 28.11%
335 $75,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $21,212 - $28,884
103 Added 28.37%
466 $129,000
Q3 2022

Nov 07, 2022

SELL
$203.3 - $244.17 $1,626 - $1,953
-8 Reduced 2.16%
363 $76,000
Q2 2022

Aug 09, 2022

BUY
$174.81 - $241.14 $64,854 - $89,462
371 New
371 $87,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $1.09 Million - $1.27 Million
-5,898 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$179.86 - $214.88 $687,964 - $821,916
3,825 Added 184.52%
5,898 $1.09 Million
Q2 2021

Aug 12, 2021

BUY
$170.47 - $211.93 $353,384 - $439,330
2,073 New
2,073 $371,000
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $127,235 - $189,585
-1,249 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$99.9 - $121.13 $124,775 - $151,291
1,249 New
1,249 $126,000
Q1 2020

May 13, 2020

SELL
$79.39 - $115.35 $136,550 - $198,402
-1,720 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$78.31 - $95.34 $134,693 - $163,984
1,720 New
1,720 $151,000
Q3 2019

Nov 12, 2019

SELL
$74.85 - $85.99 $261,974 - $300,965
-3,500 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$76.06 - $120.81 $266,210 - $422,835
3,500 New
3,500 $273,000
Q4 2017

Feb 12, 2018

SELL
$118.58 - $151.28 $115,615 - $147,498
-975 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$114.6 - $136.81 $111,735 - $133,389
975
975 $114,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.